{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:27:35Z","timestamp":1778812055142,"version":"3.51.4"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":2524,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1111\/j.1469-0691.2007.01859.x","type":"journal-article","created":{"date-parts":[[2008,2,8]],"date-time":"2008-02-08T17:29:04Z","timestamp":1202491744000},"page":"166-168","source":"Crossref","is-referenced-by-count":19,"special_numbering":"S1","title":["Breakpoints for extended-spectrum \u03b2-lactamase-producing Enterobacteriacae: pharmacokinetic\/pharmacodynamic considerations"],"prefix":"10.1016","volume":"14","author":[{"given":"A.","family":"MacGowan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2007.01859.x_bib1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJMra041359","article-title":"The new \u03b2-lactamases","volume":"352","author":"Jacoby","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2007.01859.x_bib2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1086\/313719","article-title":"Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum \u03b2-lactamase production in Klebsiella pneumoniae isolates causing bacteraemia","volume":"430","author":"Paterson","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01859.x_bib3","series-title":"Antimicrobial pharmacodynamics in theory and clinical practice","first-page":"1","article-title":"Pharmacodynamics of antimicrobials: general concepts and applications","author":"Craig","year":"2002"},{"issue":"suppl 6","key":"10.1111\/j.1469-0691.2007.01859.x_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1469-0691.2005.01265.x","article-title":"Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations","volume":"11","author":"Andes","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2007.01859.x_bib5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1128\/AAC.49.1.276-280.2005","article-title":"Pharmacodynamic profile of ertapenem against Klebsiella pneumoniae and Escherichia coli in a murine thigh model","volume":"49","author":"Maglio","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01859.x_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0732-8893(00)00185-1","article-title":"The use of Monte-Carlo simulations to examine pharmacodynamic variance of drugs: fluoroquinolone pharmacodynamics against Streptococcus pneumoniae","volume":"38","author":"Ambrose","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01859.x_bib7","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1128\/AAC.47.5.1643-1646.2003","article-title":"Pharmacokinetics\u2013pharmacodynamics of cefepime and piperacillin\u2013tazobactam against Escherichia coli and Klebsiella pneumoniae strains producing extended spectrum \u03b2-lactamases: report from ARREST Program","volume":"47","author":"Ambrose","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01859.x_bib8","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.clinthera.2004.11.009","article-title":"Pharmacodynamic modelling of carbapenems and fluoroquinolones against bacteria that produce extended spectrum beta lactamases","volume":"28","author":"Moczygemba","year":"2004","journal-title":"Clin Ther"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14604882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14604882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T21:53:16Z","timestamp":1546293196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14604882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":8,"alternative-id":["S1198743X14604882"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2007.01859.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}